Crescent Biopharma, Inc. (CBIO)
13.06
+0.70
(+5.66%)
USD |
NASDAQ |
Oct 20, 16:00
13.06
0.00 (0.00%)
After-Hours: 20:00
Crescent Biopharma Net Income (Quarterly) : -24.84M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -24.84M |
| March 31, 2026 | -23.28M |
| December 31, 2025 | -92.40M |
| September 30, 2025 | -24.61M |
| June 30, 2025 | -21.79M |
| March 31, 2025 | -15.15M |
| December 31, 2024 | -7.223M |
| September 30, 2024 | -9.824M |
| June 30, 2024 | -10.10M |
| March 31, 2024 | -10.74M |
| December 31, 2023 | -9.079M |
| September 30, 2023 | -9.202M |
| June 30, 2023 | -8.259M |
| March 31, 2023 | -10.36M |
| December 31, 2022 | -10.24M |
| September 30, 2022 | -8.524M |
| June 30, 2022 | -13.27M |
| March 31, 2022 | -14.65M |
| December 31, 2021 | -17.42M |
| September 30, 2021 | -17.33M |
| June 30, 2021 | -14.40M |
| March 31, 2021 | -14.27M |
| December 31, 2020 | -15.56M |
| September 30, 2020 | -13.72M |
| June 30, 2020 | -14.08M |
| Date | Value |
|---|---|
| March 31, 2020 | -7.663M |
| December 31, 2019 | -14.73M |
| September 30, 2019 | -13.25M |
| June 30, 2019 | -15.83M |
| March 31, 2019 | -14.08M |
| December 31, 2018 | -13.91M |
| September 30, 2018 | -11.58M |
| June 30, 2018 | -11.28M |
| March 31, 2018 | -11.51M |
| December 31, 2017 | -9.258M |
| September 30, 2017 | -7.950M |
| June 30, 2017 | -8.142M |
| March 31, 2017 | -7.931M |
| December 31, 2016 | -8.329M |
| September 30, 2016 | -7.855M |
| June 30, 2016 | -8.072M |
| March 31, 2016 | -7.555M |
| December 31, 2015 | -8.882M |
| September 30, 2015 | -7.168M |
| June 30, 2015 | 10.39M |
| March 31, 2015 | -7.109M |
| December 31, 2014 | -7.394M |
| September 30, 2014 | -6.618M |
| June 30, 2014 | 7.992M |
| March 31, 2014 | -5.102M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Encompass Health Corp. | 207.60M |
| Myriad Genetics, Inc. | -43.20M |
| BioRestorative Therapies, Inc. | -2.154M |
| Marijuana, Inc. | -0.2711M |
| Veltex Corp. | -0.2779M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 24.84M |
| EPS Diluted (Quarterly) | -0.8135 |
| Enterprise Value | 176.91M |
| Earnings Yield | -58.56% |
| Normalized Earnings Yield | -58.56 |